Search

Search Constraints

You searched for: Author/Creator Ho, Bao

Search Results

1. 68Ga‐PSMA has a high detection rate of prostate cancer recurrence outside the prostatic fossa in patients being considered for salvage radiation treatment. (24th January 2016)

2. 68Ga‐PSMA‐PET/CT staging prior to definitive radiation treatment for prostate cancer. Issue 4 (16th April 2018)

5. Advances in knowledge discovery and data mining. 22nd Pacific-Asia Conference, PAKDD 2018, Melbourne, VIC, Australia, June 3-6, 2018, Proceedings /: 22nd Pacific-Asia Conference, PAKDD 2018, Melbourne, VIC, Australia, June 3-6, 2018, Proceedings. Part III : (2018)

6. Delineating biochemical failure with 68Ga-PSMA-PET following definitive external beam radiation treatment for prostate cancer. Issue 1 (January 2017)

7. Diagnostic accuracy of 68Ga‐prostate‐specific membrane antigen (PSMA) positron‐emission tomography (PET) and multiparametric (mp)MRI to detect intermediate‐grade intra‐prostatic prostate cancer using whole‐mount pathology: impact of the addition of 68Ga‐PSMA PET to mpMRI. (9th July 2019)

8. Diagnostic value of 68Ga‐DOTATATE PET‐CT imaging for staging of ER+/PR+ HER2‐ breast cancer patients with metastatic disease: Comparison with conventional imaging with bone scan, diagnostic CT and 18F‐FDG PET‐CT in a prospective pilot trial. Issue 6 (21st October 2021)

9. Event‐free survival after radical prostatectomy according to prostate‐specific membrane antigen‐positron emission tomography and European Association of Urology biochemical recurrence risk groups. (12th July 2022)